The 36-month PharmaLedger consortium project formally endorsed the sustainability plan of the project’s results: becoming the PharmaLedger Association.
- Based in Basel, Switzerland, the PharmaLedger Association is a not-for-profit organization that continues the progress made by the project’s use cases and deploys digital healthcare solutions.
- The PharmaLedger project implemented the approved sustainability plan and actively recruited members to join the PharmaLedger Association between October 2022 to January 2023.
The press release lists key components of PharmaLedger’s post-governance approach:
- The PharmaLedger Association aims “to enable and foster a Digital Trust Ecosystem (DTE) in healthcare through a standardized and trusted open-source platform.”
- The PharmaLedger Association joined the consortium as the 30th member of the PharmaLedger project.
- The consortium approved the bylaws of the PharmaLedger Association.
PharmaLedger’s Chairman European Forum for Good Clinical Practice Ingrid Klingmann (EFGCP), Industry Project Lead Daniel Fritz (Novartis), Project Coordinator Maria Eugenia (Xenia) Beltran (Universidad Politécnica de Madrid) and Head Serialisation & Digital Enabling Michael Ritter (Takeda) also shared their thoughts about this major transition of becoming the PharmaLedger Association.
For the remainder of 2022, the PharmaLedger project focused on “Validation and Sustainability.”
